206 related articles for article (PubMed ID: 28515456)
1. Metabolomic analysis shows differential hepatic effects of T
Iannucci LF; Cioffi F; Senese R; Goglia F; Lanni A; Yen PM; Sinha RA
Sci Rep; 2017 May; 7(1):2023. PubMed ID: 28515456
[TBL] [Abstract][Full Text] [Related]
2. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of the Effects of Long-Term 3,5-diiodothyronine Treatment on the Murine Hepatic Proteome and Transcriptome Under Conditions of Normal Diet and High-Fat Diet.
Lietzow J; Golchert J; Pietzner M; Völker U; Poutanen M; Ohlsson C; Homuth G; Köhrle J
Thyroid; 2021 Jul; 31(7):1135-1146. PubMed ID: 33637021
[No Abstract] [Full Text] [Related]
4. Action of Thyroid Hormones, T3 and T2, on Hepatic Fatty Acids: Differences in Metabolic Effects and Molecular Mechanisms.
Damiano F; Rochira A; Gnoni A; Siculella L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362337
[TBL] [Abstract][Full Text] [Related]
5. 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.
Vatner DF; Snikeris J; Popov V; Perry RJ; Rahimi Y; Samuel VT
PLoS One; 2015; 10(10):e0140837. PubMed ID: 26485433
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development.
Xu Y; Han J; Dong J; Fan X; Cai Y; Li J; Wang T; Zhou J; Shang J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862046
[TBL] [Abstract][Full Text] [Related]
7. 3,5-diiodothyronine (3,5-T2) reduces blood glucose independently of insulin sensitization in obese mice.
da Silva Teixeira S; Filgueira C; Sieglaff DH; Benod C; Villagomez R; Minze LJ; Zhang A; Webb P; Nunes MT
Acta Physiol (Oxf); 2017 Jun; 220(2):238-250. PubMed ID: 27770485
[TBL] [Abstract][Full Text] [Related]
8. Exercise restores bioavailability of hydrogen sulfide and promotes autophagy influx in livers of mice fed with high-fat diet.
Wang B; Zeng J; Gu Q
Can J Physiol Pharmacol; 2017 Jun; 95(6):667-674. PubMed ID: 28177674
[TBL] [Abstract][Full Text] [Related]
9. Pathways affected by 3,5-diiodo-l-thyronine in liver of high fat-fed rats: evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry.
Silvestri E; Cioffi F; Glinni D; Ceccarelli M; Lombardi A; de Lange P; Chambery A; Severino V; Lanni A; Goglia F; Moreno M
Mol Biosyst; 2010 Nov; 6(11):2256-71. PubMed ID: 20844788
[TBL] [Abstract][Full Text] [Related]
10. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
12. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
[TBL] [Abstract][Full Text] [Related]
14. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
Yan H; Gao Y; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):180-186. PubMed ID: 27909723
[TBL] [Abstract][Full Text] [Related]
17. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
18. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y
Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143
[TBL] [Abstract][Full Text] [Related]
19. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
[TBL] [Abstract][Full Text] [Related]
20. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.
Morris EM; Meers GM; Koch LG; Britton SL; Fletcher JA; Fu X; Shankar K; Burgess SC; Ibdah JA; Rector RS; Thyfault JP
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E749-E760. PubMed ID: 27600823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
